A controversial Tennessee bill, which prohibits pharmacy benefit managers (PBMs) from owning pharmacies, has advanced in the House subcommittee. The bill, sponsored by Bobby Harshbarger in the Senate, aims to address concerns over PBM practices, including potential conflicts of interest and high reimbursement rates. CVS, a major player in the industry, is ramping up its opposition, arguing that the bill would lead to job losses and disrupt patient access to healthcare. However, supporters of the bill, including the Tennessee Pharmacists Association, highlight the need for reform to ensure fair competition and better patient care. The debate centers around the potential consequences of separating CVS's pharmacies and Caremark, with some arguing that it could be a viable solution to address the concerns raised by the bill. The bill now moves to the House Insurance Committee, where further discussions and potential amendments will take place. This development raises important questions about the future of the PBM industry and the balance between corporate interests and patient welfare.
